| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $297.1M | -8.0% |
| Cost of Revenue | $128.6M | +71.2% |
| R&D Expense | $22.7M | +11.8% |
| SG&A Expense | $130.8M | +25.4% |
| Operating Income | $30.7M | -23.1% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | $1.8M | -85.7% |
| Income Tax | -$63.0M | -1360.0% |
| Net Income | $64.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $65.4M | +61.1% |
| Inventory | $28.0M | -13.3% |
| Current Assets | $159.9M | +4.9% |
| Total Assets | $438.4M | +28.6% |
| Current Liabilities | $104.0M | +3.3% |
| Long-term Debt | $313.2M | -1.7% |
| Total Liabilities | $441.7M | +5.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $31.7M | -30.3% |
| Capital Expenditures | $17.0M | -48.2% |
| Investing Cash Flow | -$40.1M | +17.1% |
| Financing Cash Flow | -$1.6M | -109.9% |
| Free Cash Flow | $14.7M | +15.7% |
| +752.6% |
| EPS (Basic) | $2.27 | +740.7% |
| EPS (Diluted) | $2.22 | +753.8% |
| Stockholders' Equity |
| -$3.3M |
| +95.8% |